TopNewsToday.org
»
»
»

FDA panel backs Gilead’s Truvada to prevent HIV

canada.com (2 years and 2 months ago)

May 11, 2012

A U.S. Food and Drug Administration panel of outside experts recommended Gilead Sciences Inc’s Truvada as a treatment for preventing HIV infection among people at risk for contracting AIDS, including homosexual and bisexual men. full story

More news more news

FDA panel backs Gilead’s Truvada to prevent HIV

canada.com (2 years and 2 months ago)

HIV advocates say Truvada could save lives

cbsnews.com (2 years and 2 months ago)

Truvada for HIV prevention backed by advisory panel, FDA may decide by June

cbsnews.com (2 years and 2 months ago)

FDA panel recommends Gilead's Quad for HIV

yahoo.com (2 years and 2 months ago)

Pill to prevent HIV gets an FDA endorsement

latimes.com (2 years and 2 months ago)

FDA panel recommends Gilead's Quad for HIV

reuters.com (2 years and 2 months ago)

Video: JP Morgan loses $2B, FDA backs HIV prevention drug

cbsnews.com (2 years and 2 months ago)

FDA panel backs drug to prevent HIV infection risk

cbsnews.com (2 years and 2 months ago)

Video: FDA eyes unprecedented HIV prevention drug

cbsnews.com (2 years and 2 months ago)

FDA Advisers Back Pill to Help Prevent HIV Infection

yahoo.com (2 years and 2 months ago)

More World news »

Most read

Most popular

Follow us

Facebook
Twitter
Google+
RSS Feed
US | Sport | Business | Technology | Lifestyle | Entertainment | World | Search
Privacy Policy | About | Contacts
All news and photos belong to their authors.